These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 6486831

  • 1. [Direct antitumor activity of biological response modifiers (B.R.M.) proven by an in vitro sensitivity test].
    Yanagawa T, Oguro M, Takagi T, Takenaga K.
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2155-62. PubMed ID: 6486831
    [Abstract] [Full Text] [Related]

  • 2. [Augmentation of the cytostatic activity of granulocytes by biological response modifiers (BRM)].
    Shimizu E, Saijo N, Shibuya M, Takizawa T, Fujioka Y, Hoshi A.
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):2030-5. PubMed ID: 6577815
    [Abstract] [Full Text] [Related]

  • 3. [Antitumor effect of intratumoral administration of BRM: inhibition of tumor cell invasion in vitro].
    Ebina T, Murata K.
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1626-8. PubMed ID: 7574777
    [Abstract] [Full Text] [Related]

  • 4. Effects of biological response modifiers on childhood ALL being in remission after chemotherapy.
    Kawa K, Konishi S, Tsujino G, Mabuchi S.
    Biomed Pharmacother; 1991 Sep; 45(2-3):113-6. PubMed ID: 1912366
    [Abstract] [Full Text] [Related]

  • 5. Immunopotentiating action of streptococcal preparation OK-432 and protein-bound polysaccharide PS-K on depressed state of cell-mediated and humoral immunities of Friend leukemia virus infected mice.
    Kiyohashi A.
    Nihon Gan Chiryo Gakkai Shi; 1981 Aug 20; 16(4):641-6. PubMed ID: 7328350
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro augmentation of cytotoxicity by N-CWS in peritoneal polymorphonuclear leukocytes (PMNs) induced by PSK, OK-432 or N-CWS.
    Kato H, Yamamura Y, Inoue M, Tanigawa M, Kimura S, Sugino S, Kondo M.
    Biotherapy; 1992 Aug 20; 4(1):69-73. PubMed ID: 1543653
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxic and cytostatic effects of the streptococcal preparation OK-432 and its subcellular fractions on human ovarian tumor cells.
    Nio Y, Zighelboim J, Berek J, Bonavida B.
    Cancer; 1989 Jul 15; 64(2):434-41. PubMed ID: 2736490
    [Abstract] [Full Text] [Related]

  • 11. Chemoimmunotherapy of L1210 leukemia with adriamycin, cyclophosphamide, and OK-432, and their effects on the generation of antitumor immunity.
    Ujiie T.
    Jpn J Cancer Res; 1987 Jul 15; 78(7):737-47. PubMed ID: 3114200
    [Abstract] [Full Text] [Related]

  • 12. [Antitumor effect of OK-432 (1)--antitumor effect of OK-432 induced interferon-gamma (IFN gamma)].
    Saito M, Yamaguchi T, Aonuma E, Noda T, Edina T, Ishida N.
    Gan To Kagaku Ryoho; 1982 Nov 15; 9(11):2031-7. PubMed ID: 6820888
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Antitumor effect of OK-432 (3)--mechanisms of tumor growth inhibition by OK-432 induced activated macrophages].
    Nanjo M, Saito M, Aonuma E, Fujimura H, Nakamura T, Aso H, Yoshie O, Ebina T, Ishida N.
    Gan To Kagaku Ryoho; 1985 Apr 15; 12(4):887-93. PubMed ID: 3885861
    [Abstract] [Full Text] [Related]

  • 16. [Anticancer effects of OK-432 (2). Anticancer actions of M phi activated by OK-432].
    Saito M, Aonuma E, Noda T, Nakadate I, Nanjo M, Ebina T, Ishida N.
    Gan To Kagaku Ryoho; 1983 May 15; 10(5):1363-71. PubMed ID: 6870302
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synergistic actions of picibanil (OK-432) on recombinant interleukin-2 induction of tumor-infiltrating lymphocyte expansion, cytotoxicity, and phenotypic differentiation.
    Lafreniere R, Borkenhagen K, Bryant LD, Ng E, Hayton S.
    J Biol Response Mod; 1990 Feb 15; 9(1):53-60. PubMed ID: 2181072
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.